Shalom Madar
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Oncology 16
- Cancer-related Molecular Pathways 11
- Cancer Cells and Metastasis 3
- Co-authors
- Varda Rotter (24 shared papers)Ido Goldstein (17 shared papers)Naomi Goldfinger (20 shared papers)Ran Brosh (12 shared papers)Hilla Solomon (10 shared papers)Ira Kogan-Sakin (8 shared papers)Yosef Buganim (9 shared papers)Alina Molchadsky (7 shared papers)
- Journals
- Carcinogenesis (4 papers)PLoS ONE (3 papers)Cancer Research (3 papers)Trends in Molecular Medicine (2 papers)Cell Death and Differentiation (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Shalom Madar
26 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 583
- Oncology 736
- Molecular Biology 1.0k
- Biotechnology 86
- Immunology 163
Countries citing papers authored by Shalom Madar
This map shows the geographic impact of Shalom Madar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalom Madar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalom Madar more than expected).
Fields of papers citing papers by Shalom Madar
This network shows the impact of papers produced by Shalom Madar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalom Madar. The network helps show where Shalom Madar may publish in the future.
Co-authors
The 25 scholars most cited alongside Shalom Madar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 275 | |
| 2 | 2008 | 132 | |
| 3 | 2010 | 130 | |
| 4 | 2012 | 93 | |
| 5 | 2011 | 90 | |
| 6 | 2011 | 83 | |
| 7 | 2009 | 71 | |
| 8 | 2008 | 70 | |
| 9 | 2010 | 64 | |
| 10 | 2013 | 64 | |
| 11 | 2007 | 61 | |
| 12 | 2012 | 58 | |
| 13 | 2009 | 56 | |
| 14 | 2012 | 55 | |
| 15 | 2010 | 49 | |
| 16 | 2012 | 44 | |
| 17 | 2010 | 36 | |
| 18 | 2013 | 36 | |
| 19 | 2011 | 36 | |
| 20 | 2012 | 34 |
About Shalom Madar
Shalom Madar is a scholar working on Molecular Biology, Oncology, Cancer Research, Infectious Diseases and Organic Chemistry, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer-related gene regulation (4 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers), Mesenchymal stem cell research (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (583 citations), Oncology (736 citations), Molecular Biology (1.0k citations), Biotechnology (86 citations) and Immunology (163 citations). Shalom Madar has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Varda Rotter, Ido Goldstein, Naomi Goldfinger, Ran Brosh, Hilla Solomon, Ira Kogan-Sakin, Yosef Buganim, Alina Molchadsky, Osnat Ezra and Noa Rivlin. Their work appears in journals such as Carcinogenesis, PLoS ONE, Cancer Research, Trends in Molecular Medicine and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.